GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hyundai Bioscience Co 048410.KQ · KRW

Consumer Staples · KOSDAQ · 🇰🇷 South Korea

Compare

5,410

-4.08%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hyundai Bioscience Co

Its shares trade on KOSDAQ under the ticker 048410.KQ. It has been listed since 8 August 2002. In the fiscal year to 31 December 2025, it reported revenue of ₩3.52bn and a net loss of ₩22.13bn. At that date it held total assets of ₩130.74bn and shareholders' equity of ₩110.73bn.

HYUNDAI BIOSCIENCE Co., Ltd. engages in the manufacture and sale of bio-cosmetics and hair tonics. The company is headquartered in Gimcheon, Gyeongsangbuk-Do. The company went IPO on 2002-08-08. The company develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The firm also sells liquid crystal display (LCD) monitors and digital signage display products. The firm distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
8 Aug 2002

Leadership

Pay as last reported

  • Mr. Sang Gi OhChief Executive Officer, Director, since 2013
  • Mr. Taek Seong KimVice President, Director
  • Yeong Gwon JungVice President, since 2012
  • Mr. Gwang Hui KimManaging Director
  • Mr. Yong Ho ChoInternal Auditor
  • Mr. Geun Wu JinDirector
  • Mr. Gyeong Yil KimDirector, since 2012
  • Mr. Jae Mun BaeNon-Executive Independent Director
  • Mr. Jong Seon ParkNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Hyundai Bioscience manufactures bio-cosmetics and hair tonics in Gimcheon, South Korea.
  • The company develops functional daily necessities like shampoos and mask packs for domestic and international markets.
  • Hyundai Bioscience sells LCD monitors and digital signage displays alongside its consumer products.

Weaknesses

  • Hyundai Bioscience's product range includes tumor-targeted drugs, which may face regulatory challenges.
  • The company's reliance on domestic market sales could limit growth potential.
  • Hyundai Bioscience's focus on traditional consumer products may not align with emerging trends.

Opportunities

  • Expanding into European and American markets for bio-cosmetics and hair tonics.
  • Growing demand for functional daily necessities like creams and mask packs globally.
  • Increasing market share in LCD monitors and digital signage displays in Asia.

Threats

  • Competition from established cosmetic brands in Europe and America.
  • Regulatory hurdles for tumor-targeted drug development in international markets.
  • Economic downturns affecting consumer spending on non-essential products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.